Hims & Hers Health (HIMS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
28 Apr, 2026Voting matters and shareholder proposals
Election of nine directors, including Andrew Dudum, Kofi Amoo-Gottfried, Deb Autor, Delos Cosgrove, Anja Manuel, Christopher Payne, Andrea Perez, Kåre Schultz, and David Wells, is up for shareholder vote.
Ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, is proposed.
Advisory approval of executive compensation is included as a say-on-pay proposal.
Additional business may be transacted as may properly come before the meeting or any adjournment.
Board of directors and corporate governance
The board recommends voting in favor of all director nominees and proposals.
The annual meeting will be held virtually on June 11, 2026, at 11:00 a.m. Pacific Time.
Audit committee and external auditor matters
KPMG LLP is nominated for ratification as the independent registered public accounting firm for the 2026 fiscal year.
Latest events from Hims & Hers Health
- Proxy covers director elections, auditor ratification, and executive pay, highlighting strong growth and governance.HIMS
Proxy filing28 Apr 2026 - Personalized care, tech-driven growth, and global expansion fuel strong revenue and margin outlook.HIMS
Morgan Stanley Technology, Media & Telecom Conference 20262 Mar 2026 - 2025 revenue up 59% to $2.35B, with strong subscriber and specialty growth, and robust 2026 outlook.HIMS
Q4 202524 Feb 2026 - Q2 revenue up 52% to $315.6M, net income $13.3M, strong subscriber and margin growth.HIMS
Q2 20242 Feb 2026 - Personalized, tech-driven healthcare and GLP-1s fuel rapid growth and operational gains.HIMS
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Directors were elected, auditor ratified, and executive pay approved; results to be filed.HIMS
AGM 20241 Feb 2026 - Q3 2024 revenue up 77% to $401.6M, net income $75.6M, and 2M subscribers.HIMS
Q3 202417 Jan 2026 - 2024 revenue up 69% to $1.5B, net income $126M, 2025 guidance set at $2.3–$2.4B revenue.HIMS
Q4 20247 Jan 2026 - Q1 revenue up 111% to $586M, with strong subscriber growth and raised full-year guidance.HIMS
Q1 202520 Dec 2025